18F-FDG PET/CT surveillance at 3-6 and 12 months for detection of recurrence and second primary cancer in patients with head and neck squamous cell carcinoma
Menée sur 143 patients atteints d'un carcinome épidermoïde de la tête et du cou, cette étude évalue, par rapport à des examens physiques ou endoscopiques réguliers, la sensibilité d'une tomographie numérique par émission de positrons à base de fluorodésoxyglucose (18F) pour détecter une récidive entre 3 et 6 mois puis 12 mois après un traitement curatif
Background : Early detection of recurrence of head and neck squamous cell carcinoma (HNSCC), which is often obscured by surgical or radiotherapy-induced tissue distortion, is essential for proper patient management.
Methods : A total of 143 consecutive patients with previously untreated HNSCC were evaluated by whole-body fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) and regular clinical follow-up after curative treatment. The 18F-FDG PET/CT was performed ~3–6 and 12 months after treatment and findings suspicious for recurrence or SPC were confirmed using histopathology.
Results : The sensitivities of 3–6- and 12-month PET/CT scans at patient level were 96% and 93%, respectively, and those of regular clinical follow-up were 11% and 19%, respectively (McNemar test, P<0.001). In patients with no clinical suspicion, PET/CT detected 95% and 91% of recurrent patients at 3–6 and 12 months, respectively. The sensitivity of PET/CT for the identification of SPC was 29% and 80% at 3–6 and 12 months, respectively. A positive interpretation of PET/CT was significantly associated with poor overall survival (log-rank test, P<0.001).
Conclusion : The 18F-FDG PET/CT surveillance is beneficial for the detection of recurrence that may be missed by regular follow-up physical and endoscopic examinations of the head and neck area after curative treatment for HNSCC.
British Journal of Cancer , résumé, 2012